SFDA Announces Annual Adverse Event Report
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA has released the national adverse drug reaction monitoring report for 2012, which reported 1.2 million ADRs, including 74.8% from health institutes, 24.4% from producers and sellers, and 0.8% from individuals.